InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-25.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Hassan Fred, 董事. Insider active across 4 companies, notably BridgeBio Pharma, Inc.. In total, 17 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €1.2m. Activity tracked since 29 December 2021. The latest transaction was disclosed on 10 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hassan Fred
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
3,990 股Common StockSEC:0001470831-26-000629:0
71,839 股Common StockSEC:0000950103-26-003833:0
17,948 股@ US$3.514.6% 占其流量Common StockSEC:0000950103-26-003687:0
359,713 股@ US$1.39100.0% 占其流量Common StockSEC:0001493152-25-020221:0
6,589 股0Common StockSEC:0000950170-25-089647:0
36,206 股@ US$1.745.1% 占其流量Common StockSEC:0000950103-25-003518:0
8,067 股Common StockSEC:0001493152-24-040899:0
44,055 股@ US$1.435.1% 占其流量Common StockSEC:0000950103-24-003955:0
106,837 股Common StockSEC:0000950103-24-003746:0
570,345 股@ US$1.7580.7% 占其流量Common StockSEC:0000950103-23-012143:0
标准退出：2023年11月12日 (T+90)
2,123 股Common StockSEC:0000899243-23-015758:0
2,123 股0Common StockSEC:0001209191-23-031175:0
48,290 股@ US$1.174.7% 占其流量Common StockSEC:0000950103-23-004007:0
61,576 股Common StockSEC:0000950103-23-003029:0
16,212 股Common StockSEC:0000950103-22-005404:0
27,832 股@ US$2.034.2% 占其流量Common StockSEC:0000950103-22-003221:0
19,300 股@ US$14.1653100.0% 占其流量Common StockSEC:0000899243-22-000176:0
标准退出：2022年3月29日 (T+90)
17 条申报中的 17 条
About Hassan Fred
Hassan Fred is Administrateur and appears in 17 filings. Across the 17 tracked filings, the transactions span 2022-01-03 to 2026-06-24, with EUR 1156484 of buys and EUR 0 of sells; the main filings concern Precigen, INC., Cocrystal Pharma, Inc., and BridgeBio Pharma, Inc.
